 | • レポートコード：GIR201113227 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、リラグルチド薬の世界市場を調査対象にし、リラグルチド薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ヴィクトーザ、サクセンダ）、用途別分析（2型糖尿病、肥満）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Novo Nordisk、Mylan ・メーカー別販売量、売上、市場シェア ・リラグルチド薬の地域別市場分析 ・リラグルチド薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・リラグルチド薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・リラグルチド薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・リラグルチド薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・リラグルチド薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・リラグルチド薬の種類別市場規模2015-2020：ヴィクトーザ、サクセンダ ・リラグルチド薬の用途別市場規模2015-2020：2型糖尿病、肥満 ・リラグルチド薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Liraglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Liraglutide Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Liraglutide Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liraglutide Drugs market has been segmented into
Victoza
Saxenda
By Application, Liraglutide Drugs has been segmented into:
Type 2 Diabetes
Obesity
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liraglutide Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Liraglutide Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liraglutide Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Liraglutide Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liraglutide Drugs Market Share Analysis
Liraglutide Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liraglutide Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liraglutide Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Liraglutide Drugs are:
Novo Nordisk
Mylan
Among other players domestic and global, Liraglutide Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liraglutide Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liraglutide Drugs, with price, sales, revenue and global market share of Liraglutide Drugs in 2018 and 2019.
Chapter 3, the Liraglutide Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liraglutide Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liraglutide Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liraglutide Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Liraglutide Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liraglutide Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Victoza
1.2.3 Saxenda
1.3 Market Analysis by Application
1.3.1 Overview: Global Liraglutide Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type 2 Diabetes
1.3.3 Obesity
1.4 Overview of Global Liraglutide Drugs Market
1.4.1 Global Liraglutide Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Liraglutide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mylan SWOT Analysis
2.2.4 Mylan Product and Services
2.2.5 Mylan Liraglutide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liraglutide Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liraglutide Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liraglutide Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Liraglutide Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liraglutide Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Liraglutide Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liraglutide Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Liraglutide Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Liraglutide Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liraglutide Drugs Sales and Growth Rate (2015-2020)
4.5 South America Liraglutide Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liraglutide Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liraglutide Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Liraglutide Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Liraglutide Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Liraglutide Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Liraglutide Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Liraglutide Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liraglutide Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Liraglutide Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liraglutide Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Liraglutide Drugs Sales and Growth Rate (2015-2020)
6.3 UK Liraglutide Drugs Sales and Growth Rate (2015-2020)
6.4 France Liraglutide Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Liraglutide Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Liraglutide Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liraglutide Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liraglutide Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liraglutide Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Liraglutide Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Liraglutide Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Liraglutide Drugs Sales and Growth Rate (2015-2020)
7.5 India Liraglutide Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liraglutide Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Liraglutide Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liraglutide Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Liraglutide Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Liraglutide Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liraglutide Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Liraglutide Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liraglutide Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liraglutide Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liraglutide Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liraglutide Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Liraglutide Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Liraglutide Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Liraglutide Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liraglutide Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Liraglutide Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Liraglutide Drugs Price by Type (2015-2020)
11 Global Liraglutide Drugs Market Segment by Application
11.1 Global Liraglutide Drugs Sales Market Share by Application (2015-2020)
11.2 Global Liraglutide Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Liraglutide Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liraglutide Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Liraglutide Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Liraglutide Drugs Market Forecast (2021-2025)
12.2.2 Europe Liraglutide Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liraglutide Drugs Market Forecast (2021-2025)
12.2.4 South America Liraglutide Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liraglutide Drugs Market Forecast (2021-2025)
12.3 Liraglutide Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Liraglutide Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Liraglutide Drugs Market Share Forecast by Type (2021-2025)
12.4 Liraglutide Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Liraglutide Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Liraglutide Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liraglutide Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liraglutide Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liraglutide Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 8. Novo Nordisk Liraglutide Drugs Major Business
Table 9. Novo Nordisk Liraglutide Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Novo Nordisk SWOT Analysis
Table 11. Novo Nordisk Liraglutide Drugs Product and Services
Table 12. Novo Nordisk Liraglutide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Liraglutide Drugs Major Business
Table 15. Mylan Liraglutide Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Mylan SWOT Analysis
Table 17. Mylan Liraglutide Drugs Product and Services
Table 18. Mylan Liraglutide Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Liraglutide Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Liraglutide Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Liraglutide Drugs Sales by Regions (2015-2020) (K Units)
Table 22. Global Liraglutide Drugs Sales Market Share by Regions (2015-2020)
Table 23. Global Liraglutide Drugs Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 25. North America Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 26. North America Liraglutide Drugs Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 28. Europe Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 29. Europe Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 30. Europe Liraglutide Drugs Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Liraglutide Drugs Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Liraglutide Drugs Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Liraglutide Drugs Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 35. South America Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 36. South America Liraglutide Drugs Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Liraglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Liraglutide Drugs Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 42. Global Liraglutide Drugs Sales by Type (2015-2020) (K Units)
Table 43. Global Liraglutide Drugs Sales Share by Type (2015-2020)
Table 44. Global Liraglutide Drugs Revenue by Type (2015-2020) (USD Million)
Table 45. Global Liraglutide Drugs Revenue Share by Type (2015-2020)
Table 46. Global Liraglutide Drugs Sales by Application (2015-2020) (K Units)
Table 47. Global Liraglutide Drugs Sales Share by Application (2015-2020)
Table 48. Global Liraglutide Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Liraglutide Drugs Market Share Forecast by Regions (2021-2025)
Table 50. Global Liraglutide Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Liraglutide Drugs Market Share Forecast by Type (2021-2025)
Table 52. Global Liraglutide Drugs Sales Forecast by Application (2021-2025)
Table 53. Global Liraglutide Drugs Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liraglutide Drugs Picture
Figure 2. Global Sales Market Share of Liraglutide Drugs by Type in 2019
Figure 3. Victoza Picture
Figure 4. Saxenda Picture
Figure 5. Liraglutide Drugs Sales Market Share by Application in 2018
Figure 6. Type 2 Diabetes Picture
Figure 7. Obesity Picture
Figure 8. Global Liraglutide Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Liraglutide Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Liraglutide Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Liraglutide Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Liraglutide Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Liraglutide Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Liraglutide Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Liraglutide Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Liraglutide Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Liraglutide Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Liraglutide Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Liraglutide Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Liraglutide Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Liraglutide Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Liraglutide Drugs Sales Market Share by Countries in 2018
Figure 45. North America Liraglutide Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Liraglutide Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Liraglutide Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Liraglutide Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Liraglutide Drugs Revenue Market Share by Regions 2019
Figure 61. China Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Liraglutide Drugs Sales Market Share by Countries in 2019
Figure 68. South America Liraglutide Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Liraglutide Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Liraglutide Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Liraglutide Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Liraglutide Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Liraglutide Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Liraglutide Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Liraglutide Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Liraglutide Drugs Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Liraglutide Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Liraglutide Drugs Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Liraglutide Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Liraglutide Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
リラグルチドの世界市場 2020年 Market Overview The Liraglutide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- エクセナチド薬の世界市場 2020年 Market Overview The global Exenatide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exenatide Drugs market report…
- テデュグルチド薬の世界市場 2020年 Market Overview The global Teduglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Teduglutide Drugs market re…
- ニボルマブ薬の世界市場 2020年 Market Overview The Nivolumab Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 糖尿病ケア機器・薬物の世界市場 2020年 Market Overview The global Diabetes Care Devices & Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Diabetes Care D…